BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 9190928)

  • 1. Aberrant TCR-mediated signaling in CD45-null thymocytes involves dysfunctional regulation of Lck, Fyn, TCR-zeta, and ZAP-70.
    Stone JD; Conroy LA; Byth KF; Hederer RA; Howlett S; Takemoto Y; Holmes N; Alexander DR
    J Immunol; 1997 Jun; 158(12):5773-82. PubMed ID: 9190928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase.
    Deans JP; Kanner SB; Torres RM; Ledbetter JA
    Eur J Immunol; 1992 Mar; 22(3):661-8. PubMed ID: 1532148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the T-cell antigen receptor-CD3 complex signaling pathway by the tyrosine phosphatase inhibitor pervanadate is mediated by inhibition of CD45: evidence for two interconnected Lck/Fyn- or zap-70-dependent signaling pathways.
    Imbert V; Farahifar D; Auberger P; Mary D; Rossi B; Peyron JF
    J Inflamm; 1996; 46(2):65-77. PubMed ID: 8734787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p56lck SH2 domain mediates recruitment of CD8/p56lck to the activated T cell receptor/CD3/zeta complex.
    Thome M; Germain V; DiSanto JP; Acuto O
    Eur J Immunol; 1996 Sep; 26(9):2093-2100. PubMed ID: 8814252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual participation of ZAP-70 and scr protein tyrosine kinases is required for TCR-induced tyrosine phosphorylation of Sam68 in Jurkat T cells.
    Lang V; Mège D; Semichon M; Gary-Gouy H; Bismuth G
    Eur J Immunol; 1997 Dec; 27(12):3360-7. PubMed ID: 9464824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient expression of p56(lck) in Th2 cells leads to partial TCR signaling and a dysregulation in lymphokine mRNA levels.
    al-Ramadi BK; Nakamura T; Leitenberg D; Bothwell AL
    J Immunol; 1996 Dec; 157(11):4751-61. PubMed ID: 8943376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glycosylphosphatidylinositol-anchored CD59 protein stimulates both T cell receptor zeta/ZAP-70-dependent and -independent signaling pathways in T cells.
    Deckert M; Ticchioni M; Mari B; Mary D; Bernard A
    Eur J Immunol; 1995 Jul; 25(7):1815-22. PubMed ID: 7542590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
    Turka LA; Kanner SB; Schieven GL; Thompson CB; Ledbetter JA
    Eur J Immunol; 1992 Feb; 22(2):551-7. PubMed ID: 1371471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential contribution of Lck and Fyn protein tyrosine kinases to intraepithelial lymphocyte development.
    Page ST; van Oers NS; Perlmutter RM; Weiss A; Pullen AM
    Eur J Immunol; 1997 Feb; 27(2):554-62. PubMed ID: 9045930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation.
    Goldman F; Jensen WA; Johnson GL; Heasley L; Cambier JC
    J Immunol; 1994 Oct; 153(7):2905-17. PubMed ID: 7522245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical and functional interactions of protein tyrosine kinases, p59fyn and ZAP-70, in T cell signaling.
    Fusaki N; Matsuda S; Nishizumi H; Umemori H; Yamamoto T
    J Immunol; 1996 Feb; 156(4):1369-77. PubMed ID: 8568236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
    Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
    J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic cell phosphatase (HCP) regulates p56LCK phosphorylation and ZAP-70 binding to T cell receptor zeta chain.
    Raab M; Rudd CE
    Biochem Biophys Res Commun; 1996 May; 222(1):50-7. PubMed ID: 8630073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.
    Tsujikawa K; Ichijo T; Moriyama K; Tadotsu N; Sakamoto K; Sakane N; Fukada S; Furukawa T; Saito H; Yamamoto H
    Mol Cancer Res; 2002 Dec; 1(2):155-63. PubMed ID: 12496362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of CD45 protein tyrosine phosphatase activity to lipid microdomains on the T cell surface inhibits TCR signaling.
    He X; Woodford-Thomas TA; Johnson KG; Shah DD; Thomas ML
    Eur J Immunol; 2002 Sep; 32(9):2578-87. PubMed ID: 12207342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of T cells via CD55: recruitment of early components of the CD3-TCR pathway is required for IL-2 secretion.
    Tosello AC; Mary F; Amiot M; Bernard A; Mary D
    J Inflamm; 1998; 48(1):13-27. PubMed ID: 9368189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine protein kinases in T lymphocytes.
    Peri KG; Veillette A
    Chem Immunol; 1994; 59():19-39. PubMed ID: 7945927
    [No Abstract]   [Full Text] [Related]  

  • 19. Phospho-LAT-independent activation of the ras-mitogen-activated protein kinase pathway: a differential recruitment model of TCR partial agonist signaling.
    Chau LA; Madrenas J
    J Immunol; 1999 Aug; 163(4):1853-8. PubMed ID: 10438919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.
    Stefanová I; Saville MW; Peters C; Cleghorn FR; Schwartz D; Venzon DJ; Weinhold KJ; Jack N; Bartholomew C; Blattner WA; Yarchoan R; Bolen JB; Horak ID
    J Clin Invest; 1996 Sep; 98(6):1290-7. PubMed ID: 8823293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.